Literature DB >> 18164610

Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver.

Andrew D Hathaway1, Kirk I Tousaw.   

Abstract

North America's first official safe injection facility has begun to generate substantial evidence attesting to the harm reduction benefits of supervised injection. Reductions in morbidity, mortality, and crime rates have strengthened the resolve of local advocates and even influenced the views of some original detractors. Many status quo defenders are unwavering, however, in their condemnation of initiatives like InSite. The term 'drug den' has been used in right-wing media and some opponents of the programme say the evidence is biased. In their view, harm reduction advocates are really 'legalisers' in the guise of scientists and public health professionals. Providing services for people with drug problems sends the message that some use of drugs is normal, rather than affirming that drug use is the problem. Abstinence, prevention, and enforcement are the only acceptable and morally legitimate solutions. Harm reduction's muted stance on morals, rights and values prevents proponents from engaging criticisms of this nature in terms other than the evidence or science. The case of InSite in Vancouver, however, the authors argue, demonstrates the value of asserting human rights claims that do not rest on evidence per se. Scientific arguments are insufficient in themselves to move beyond the status quo on drugs. Rights-based moral warrants in support of harm reduction require far more extensive and explicit cultivation if they are to be discursively established and maintained.

Entities:  

Mesh:

Year:  2008        PMID: 18164610     DOI: 10.1016/j.drugpo.2007.11.006

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  13 in total

1.  Public health understandings of policy and power: lessons from INSITE.

Authors:  Patrick Fafard
Journal:  J Urban Health       Date:  2012-12       Impact factor: 3.671

2.  Harm reduction ethics: Acknowledging the values and beliefs behind our actions.

Authors:  Craig L Fry; Kaveh Khoshnood; Robert Power; Mukta Sharma
Journal:  Int J Drug Policy       Date:  2008-01-16

3.  Opioid-Involved Overdose Among Male Afghanistan/Iraq-Era U.S. Military Veterans: A Multidimensional Perspective.

Authors:  Alex S Bennett; Luther Elliott; Andrew Golub; Brett Wolfson-Stofko; Honoria Guarino
Journal:  Subst Use Misuse       Date:  2017-06-16       Impact factor: 2.164

4.  State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness.

Authors:  Heidi Bramson; Don C Des Jarlais; Kamyar Arasteh; Ann Nugent; Vivian Guardino; Jonathan Feelemyer; Derek Hodel
Journal:  J Public Health Policy       Date:  2015-01-15       Impact factor: 2.222

5.  6th Canadian Symposium on Hepatitis C Virus: Delivering a cure for hepatitis C infection-What are the remaining gaps?

Authors:  Sarwat Khan; Annie Bernier; Dustin Dapp; Emmanuel Fortier; Mel Krajden; Alexandra King; Jason Grebely; Selena M Sagan; Curtis L Cooper; Angela M Crawley
Journal:  Can Liver J       Date:  2018-07-17

6.  Integrating HIV care and HIV prevention: legal, policy and programmatic recommendations.

Authors:  Robert H Remien; Alan Berkman; Landon Myer; Francisco I Bastos; Ashraf Kagee; Wafaa M El-Sadr
Journal:  AIDS       Date:  2008-08       Impact factor: 4.177

7.  Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies.

Authors:  E Childs; K B Biello; P K Valente; P Salhaney; D L Biancarelli; J Olson; J J Earlywine; B D L Marshall; A R Bazzi
Journal:  Int J Drug Policy       Date:  2020-12-16

8.  CommunityStat: A Public Health Intervention to Reduce Opioid Overdose Deaths in Burlington, Vermont, 2017-2020.

Authors:  Brandon Del Pozo
Journal:  Contemp Drug Probl       Date:  2021-10-06

9.  The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.

Authors:  Bruce Wallace; Thea van Roode; Flora Pagan; Dennis Hore; Bernadette Pauly
Journal:  BMC Public Health       Date:  2021-06-16       Impact factor: 3.295

10.  A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada.

Authors:  Ehsan Jozaghi; Andrew A Reid; Martin A Andresen; Alexandre Juneau
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.